scholarly article | Q13442814 |
P356 | DOI | 10.1002/1098-2396(20000915)37:4<298::AID-SYN7>3.0.CO;2-A |
P698 | PubMed publication ID | 10891867 |
P2093 | author name string | Mehta A | |
Chesselet MF | |||
Thermos K | |||
P2860 | cites work | A role for the subthalamic nucleus in 5-HT2C-induced oral dyskinesia | Q71323714 |
Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates | Q71438213 | ||
Effects of the dopamine D1 receptor antagonist SCH 39166 on the ingestive behaviour of alcohol-preferring rats | Q71539062 | ||
Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat | Q72277088 | ||
Tardive dyskinesia | Q72578948 | ||
Dopaminergic stimulation of subthalamic nucleus elicits oral dyskinesia in rats | Q72690516 | ||
Changes in brain dopamine receptors in MPTP parkinsonian monkeys following L-dopa treatment | Q72691758 | ||
Prognosis in hemiballismus | Q74502515 | ||
The thyrotrophin-releasing hormone analogue MK771 induces tic-like behaviours: the effects of dopamine D1 and D2 receptor antagonists | Q77329251 | ||
Dopaminergic innervation of the basal ganglia in the squirrel monkey as revealed by tyrosine hydroxylase immunohistochemistry | Q28257992 | ||
Differential effects of D1 and D2 agonists in MPTP-treated primates: functional implications for Parkinson's disease | Q28329967 | ||
Dopamine receptor agonists: selectivity and dopamine D1 receptor efficacy | Q28334235 | ||
D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys | Q28371745 | ||
The functional anatomy of basal ganglia disorders | Q29617461 | ||
Primate models of movement disorders of basal ganglia origin | Q29618489 | ||
A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets | Q34245559 | ||
Ballism and the subthalamic nucleus hypothalamicus; corpus luysi) review of the literature and study of 30 cases. | Q37298378 | ||
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus | Q41241320 | ||
Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. | Q42539523 | ||
Neurotoxicity induced by the D-1 agonist SKF 38393 following microinjection into rat brain | Q43504754 | ||
The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors | Q44319553 | ||
The current model of basal ganglia organization under scrutiny | Q45295875 | ||
Different plasticity changes in D1 and D2 receptors in rat striatal subregions following impairment of dopaminergic transmission | Q48111942 | ||
The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism | Q48149918 | ||
Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study | Q48161168 | ||
Increased [125I]sulpiride binding in the subthalamic nucleus of rats with nigrostriatal lesions | Q48178832 | ||
Tyrosine hydroxylase-immunoreactive elements in the human globus pallidus and subthalamic nucleus | Q48179313 | ||
Expression of dopamine receptors in the subthalamic nucleus of the rat: characterization using reverse transcriptase-polymerase chain reaction and autoradiography | Q48189173 | ||
Differential efficacies of dopamine D1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. | Q48266857 | ||
Blockade of subthalamic dopamine D1 receptors elicits akinesia in rats | Q48295948 | ||
Chronic treatment with L-DOPA, but not bromocriptine induces dyskinesia in MPTP-parkinsonian monkeys. Correlation with [3H]spiperone binding | Q48311680 | ||
Excitatory effect of iontophoretically applied dopamine on identified neurons of the rat subthalamic nucleus | Q48334169 | ||
Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease | Q48373524 | ||
Sensitization of dopamine-stimulated adenylyl cyclase in the striatum of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated rhesus monkeys and patients with idiopathic Parkinson's disease | Q48477508 | ||
Dopaminergic mechanisms in subthalamic nucleus of rat: analysis using horseradish peroxidase and microiontophoresis | Q48488722 | ||
Evidence for a dopaminergic innervation of the subthalamic nucleus in the rat. | Q48797018 | ||
Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat. | Q48877841 | ||
The dopamine receptor adenylate cyclase complex: evidence for post recognition site involvement for the development of supersensitivity | Q49057979 | ||
Differential tolerance to cataleptic effects of SCH 23390 and haloperidol after repeated administration | Q69373474 | ||
Time dependent changes in DA uptake sites, D1 and D2 receptor binding and mRNA after 6-OHDA lesions of the medial forebrain bundle in the rat brain | Q70800697 | ||
P433 | issue | 4 | |
P921 | main subject | subthalamic nucleus | Q2270424 |
P304 | page(s) | 298-307 | |
P577 | publication date | 2000-09-01 | |
P1433 | published in | Synapse | Q7662025 |
P1476 | title | Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions | |
P478 | volume | 37 |
Q30484170 | Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson's disease |
Q44205707 | Compromised peripheral immunity of mice injected intrastriatally with six-hydroxydopamine |
Q34349190 | D1 dopamine receptors |
Q42436820 | D5 (not D1) dopamine receptors potentiate burst-firing in neurons of the subthalamic nucleus by modulating an L-type calcium conductance. |
Q82029300 | Dopamine receptor pharmacology |
Q42435952 | Excitation by dopamine of rat subthalamic nucleus neurones in vitro-a direct action with unconventional pharmacology |
Q34330022 | Extrastriatal dopaminergic circuits of the Basal Ganglia |
Q43553273 | Increased m-CPP-induced oral dyskinesia after lesion of serotonergic neurons |
Q33633995 | Involvement of dopamine loss in extrastriatal basal ganglia nuclei in the pathophysiology of Parkinson's disease. |
Q41743040 | Nigrostriatal lesions alter oral dyskinesia and c-Fos expression induced by the serotonin agonist 1-(m-chlorophenyl)piperazine in adult rats. |
Search more.